Cargando…

Cancer pain management in China: current status and practice implications based on the ACHEON survey

PURPOSE: Cancer pain can seriously impact the quality of life (QoL) of patients, and optimal management practices are therefore of paramount importance. The ACHEON survey queried physicians and patients from 10 Asian countries/regions to assess current clinical practices in cancer pain management in...

Descripción completa

Detalles Bibliográficos
Autor principal: Xia, Zhongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571848/
https://www.ncbi.nlm.nih.gov/pubmed/28860849
http://dx.doi.org/10.2147/JPR.S128533
_version_ 1783259418889027584
author Xia, Zhongjun
author_facet Xia, Zhongjun
author_sort Xia, Zhongjun
collection PubMed
description PURPOSE: Cancer pain can seriously impact the quality of life (QoL) of patients, and optimal management practices are therefore of paramount importance. The ACHEON survey queried physicians and patients from 10 Asian countries/regions to assess current clinical practices in cancer pain management in Asia. This study presents the data obtained for cancer pain management in mainland China, with an emphasis on practices related to opioid drugs. MATERIALS AND METHODS: In several tertiary hospitals across China, 250 patients experiencing cancer pain and 100 physicians were surveyed on questions designed to assess current cancer pain management practices and cancer pain impact on QoL. RESULTS: The patient survey showed that 88% of patients reported moderate-to-severe cancer pain, with a median duration of 6 months. The physician survey showed that medical school/residency training with regard to cancer pain management was inadequate in ~80% of physicians. A total of 80% of physicians and 67.2% of patients reported that pain scale was used during pain assessment; 84% of physicians expressed that physician-perceived pain severity was not completely consistent with actual pain the patient experienced. Of the 147 patients who recalled the medication received, 83.7% were administered opioid prescriptions. Of the 240 patients who received treatment, 43.8% perceived the inadequacy of controlling pain. The primary barriers from physicians perceived to optimal pain management included patients’ fear of side effects (58%), patients’ fear of addiction (53%), patients’ reluctance to report pain (43%), physicians’ reluctance to prescribe (29%), physicians’ inadequacy of pain assessment (27%) and excessive regulation of opioid analgesics (47%). CONCLUSION: Knowledge of cancer pain management should be strengthened among physicians. Quantitative pain assessment and principle-based pain management should be combined to achieve pain relief. Misconceptions about opioids in patients and physicians and poor report about pain should be overcome through training/education to improve QoL of patients impacted by pain.
format Online
Article
Text
id pubmed-5571848
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55718482017-08-31 Cancer pain management in China: current status and practice implications based on the ACHEON survey Xia, Zhongjun J Pain Res Original Research PURPOSE: Cancer pain can seriously impact the quality of life (QoL) of patients, and optimal management practices are therefore of paramount importance. The ACHEON survey queried physicians and patients from 10 Asian countries/regions to assess current clinical practices in cancer pain management in Asia. This study presents the data obtained for cancer pain management in mainland China, with an emphasis on practices related to opioid drugs. MATERIALS AND METHODS: In several tertiary hospitals across China, 250 patients experiencing cancer pain and 100 physicians were surveyed on questions designed to assess current cancer pain management practices and cancer pain impact on QoL. RESULTS: The patient survey showed that 88% of patients reported moderate-to-severe cancer pain, with a median duration of 6 months. The physician survey showed that medical school/residency training with regard to cancer pain management was inadequate in ~80% of physicians. A total of 80% of physicians and 67.2% of patients reported that pain scale was used during pain assessment; 84% of physicians expressed that physician-perceived pain severity was not completely consistent with actual pain the patient experienced. Of the 147 patients who recalled the medication received, 83.7% were administered opioid prescriptions. Of the 240 patients who received treatment, 43.8% perceived the inadequacy of controlling pain. The primary barriers from physicians perceived to optimal pain management included patients’ fear of side effects (58%), patients’ fear of addiction (53%), patients’ reluctance to report pain (43%), physicians’ reluctance to prescribe (29%), physicians’ inadequacy of pain assessment (27%) and excessive regulation of opioid analgesics (47%). CONCLUSION: Knowledge of cancer pain management should be strengthened among physicians. Quantitative pain assessment and principle-based pain management should be combined to achieve pain relief. Misconceptions about opioids in patients and physicians and poor report about pain should be overcome through training/education to improve QoL of patients impacted by pain. Dove Medical Press 2017-08-18 /pmc/articles/PMC5571848/ /pubmed/28860849 http://dx.doi.org/10.2147/JPR.S128533 Text en © 2017 Xia. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Xia, Zhongjun
Cancer pain management in China: current status and practice implications based on the ACHEON survey
title Cancer pain management in China: current status and practice implications based on the ACHEON survey
title_full Cancer pain management in China: current status and practice implications based on the ACHEON survey
title_fullStr Cancer pain management in China: current status and practice implications based on the ACHEON survey
title_full_unstemmed Cancer pain management in China: current status and practice implications based on the ACHEON survey
title_short Cancer pain management in China: current status and practice implications based on the ACHEON survey
title_sort cancer pain management in china: current status and practice implications based on the acheon survey
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571848/
https://www.ncbi.nlm.nih.gov/pubmed/28860849
http://dx.doi.org/10.2147/JPR.S128533
work_keys_str_mv AT xiazhongjun cancerpainmanagementinchinacurrentstatusandpracticeimplicationsbasedontheacheonsurvey